194 related articles for article (PubMed ID: 6816811)
1. Synergistic activation by collagen and 15-hydroxy-9 alpha,11 alpha-peroxidoprosta-5,13-dienoic acid (PGH2) of phosphatidylinositol metabolism and arachidonic acid release in human platelets.
Rittenhouse SE; Allen CL
J Clin Invest; 1982 Dec; 70(6):1216-24. PubMed ID: 6816811
[TBL] [Abstract][Full Text] [Related]
2. Mobilization of arachidonic acid in collagen-stimulated human platelets.
Vedelago HR; Mahadevappa VG
Biochem J; 1988 Dec; 256(3):981-7. PubMed ID: 3146982
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
Hecker M; Ullrich V; Fischer C; Meese CO
Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
[TBL] [Abstract][Full Text] [Related]
4. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
Gorman RR; Fitzpatrick FA; Miller OV
Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
[No Abstract] [Full Text] [Related]
5. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
6. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
[TBL] [Abstract][Full Text] [Related]
7. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
Hornberger W; Patscheke H
Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
Mayeux PR; Kadowitz PJ; McNamara DB
Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor.
Oglesby TD; Gorman RR
Biochim Biophys Acta; 1984 Apr; 793(2):269-77. PubMed ID: 6424715
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Steinbacher TE; Ogletree ML; Hall SE
Prostaglandins; 1986 Apr; 31(4):651-67. PubMed ID: 3088677
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro.
Gerrard JM; Butler AM; Graff G; Stoddard SF; White JG
Prostaglandins Med; 1978 Nov; 1(5):373-85. PubMed ID: 364508
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
Hornberger WB; Patscheke H
Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
[TBL] [Abstract][Full Text] [Related]
16. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
17. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin H2 directly lowers human platelet cAMP levels.
Rybicki JP; Le Breton GC
Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
[TBL] [Abstract][Full Text] [Related]
19. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.
Faili A; Randon J; Vargaftig BB; Hatmi M
Biochem Pharmacol; 1993 May; 45(9):1815-20. PubMed ID: 8388209
[TBL] [Abstract][Full Text] [Related]
20. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]